Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of fixed-dose combination therapy (aspirin + statin + ACE inhibitor) on adherence and risk factor control in post–myocardial infarction patients
2010-022492-54Phase 3Completed
- Sponsor
- Centro Nacional de Investigaciones Cardiovasculares
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin + atorvastatin + ramipril in myocardial infarction (MI) and cardiac morbidity (2 arms), sponsored by Centro Nacional de Investigaciones Cardiovasculares. Started Jan 2011; status: completed.
02
Drugs
aspirin + atorvastatin + ramipril
03
Conditions
myocardial infarction (MI)cardiac morbidity
Beyond the preview
Go deeper on 2010-022492-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022492-54.